Springworks Therapeutics Stock Profit Margin
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess SpringWorks Therapeutics' long-term financial health and intrinsic value.
SpringWorks |
SpringWorks Therapeutics Company Profit Margin Analysis
SpringWorks Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current SpringWorks Therapeutics Profit Margin | (1.16) % |
Most of SpringWorks Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SpringWorks Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, SpringWorks Therapeutics has a Profit Margin of -1.156%. This is 89.69% lower than that of the Biotechnology sector and 94.98% lower than that of the Health Care industry. The profit margin for all United States stocks is 8.98% lower than that of the firm.
SpringWorks Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SpringWorks Therapeutics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics of similar companies.SpringWorks Therapeutics is currently under evaluation in profit margin category among its peers.
SpringWorks Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 3.26 B | |||
| Shares Outstanding | 75.35 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 87.40 % | |||
| Number Of Shares Shorted | 6.38 M | |||
| Price To Earning | 6.14 X | |||
| Price To Book | 8.49 X | |||
| Price To Sales | 16.12 X | |||
| Revenue | 191.59 M | |||
| Gross Profit | 204.8 M | |||
| EBITDA | (278.13 M) | |||
| Net Income | (258.13 M) | |||
| Cash And Equivalents | 334.54 M | |||
| Cash Per Share | 6.81 X | |||
| Total Debt | 7.91 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 9.80 X | |||
| Book Value Per Share | 5.57 X | |||
| Cash Flow From Operations | (175.6 M) | |||
| Short Ratio | 1.46 X | |||
| Earnings Per Share | (3.41) X | |||
| Target Price | 47.0 | |||
| Number Of Employees | 368 | |||
| Beta | 0.7 | |||
| Market Capitalization | 3.54 B | |||
| Total Asset | 587.28 M | |||
| Retained Earnings | (1.15 B) | |||
| Working Capital | 280.48 M | |||
| Current Asset | 29.13 M | |||
| Current Liabilities | 10.16 M | |||
| Net Asset | 587.28 M |
About SpringWorks Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SpringWorks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SpringWorks Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SpringWorks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |